TUCSON, Arizona (July 1, 2015)—Health care M&A advisory firm Vertess announced the closing of two acquisitions by Patient Home Monitoring (PHM), a health care company with $200 million annualized revenue and a focus on diverse products and services that improve outcomes, reduce hospital readmissions and help control costs.
Vertess represented the two separate durable medical equipment (DME) companies acquired, Legacy Oxygen, a Kentucky-based company with $3.5 million annual revenue, and Sleep Management, a Louisiana-based company with $45 million annualized revenue and operations in 19 states. PHM has since formally announced that it is initiating the process to graduate to the TSX Senior Exchange.
“We are continuing to strengthen our position as successful M&A advisors for DME and related health care companies across the U.S.,” said Bradley Smith, the Vertess managing director/partner who represented both Legacy Oxygen and Sleep Management in the transactions. “There are outstanding opportunities for both sellers and investors in this marketplace.”
Vertess is a health care-focused M&A advisory firm with expertise in diverse health care and human service verticals, ranging from behavioral health and intellectual/developmental disabilities to DME, home care/hospice, urgent care and other specialized services and products.
For more information, visit vertess.com.
